Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216859 · ClinicalTrials.gov registry record · NA
Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)
A NA study, sponsored by Kaiser Permanente.
- Not yet
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
NCT07216859 is a NA study that has not yet begun recruiting, run by Kaiser Permanente. The registered enrollment target is 2,000 participants.
The verdict
NCT07216859, a NA study, has not yet begun recruiting, sponsored by Kaiser Permanente.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
Study Summary
The goal of this prospective, multicenter, open-label, blinded end-point pragmatic study is to evaluate an artificial intelligence (AI)-augmented echocardiography screening approach for early detection of metabolic dysfunction associated steatotic liver disease (MASLD) and/or cirrhosis, in patients undergoing routine transthoracic echocardiograms (TTEs). The main question it aims to answer is to: 1. Evaluate notification responsiveness and rates of confirmatory testing for patients identified as high risk for having liver disease to determine whether optimized notifications increase timely confirmatory testing and treatment initiation versus standard of care assessment. 2. Compare time to diagnosis, treatment uptake, and clinical outcomes (hospitalizations, incident ASCVD, mortality) between cohorts identified as high risk by the AI algorithm and comparison groups to determine whether AI guided screening shortens time to diagnosis and increases appropriate treatment.
Interventions
- OTHER AI-Enabled Identification (EchoNet-Liver)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2027-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07216859
The ClinicalTrials.gov registry entry for NCT07216859 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AI-Enabled Identification (EchoNet-Liver) is the first listed.
NCT07216859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07216859 about?
NCT07216859 is a clinical study titled "Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)". The goal of this prospective, multicenter, open-label, blinded end-point pragmatic study is to evaluate an artificial intelligence (AI)-augmented echocardiography screening approach for early detection of metabolic dysfunction associated steatotic liver disease (MASLD) and/or cirrhosis, in patients ...
What is the current status of trial NCT07216859?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2026-01-01. Estimated completion is 2027-11-01.
What interventions are being tested in trial NCT07216859?
The interventions under investigation include: AI-Enabled Identification (EchoNet-Liver) (OTHER).
Who is sponsoring clinical trial NCT07216859?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.